Specifically, inhibition of BMP-1 activity markedly enhanced anti-proleferative effects of doxorubicin, a commonly used chemotherapeutic drug, in both highly metastatic murine mammary and human mammary cancer cells. Here, BMP1 is linked to breast cancer.